Global Partnership to Introduce a Connected, Point-of-Care Diagnostic Platform for COVID-19 Antigen Testing in Africa -- COMPAMED Trade Fair

10.11.2020

LumiraDx UK Ltd

Global Partnership to Introduce a Connected, Point-of-Care Diagnostic Platform for COVID-19 Antigen Testing in Africa

London, UK – LumiraDx, the next generation point-of-care diagnostic company, announced today a $32 million global partnership with Africa Union, Africa Centres for Disease Control and Prevention (Africa CDC), Africa Medical Supplies Platform (AMSP), Bill and Melinda Gates Foundation (BMGF), and Clinton Health Access Initiative (CHAI) with the support of the COVID-19 Therapeutics Accelerator, The Mastercard Foundation and The Rockefeller Foundation to expand access to fast, accurate and equitable COVID-19 testing in Africa.

Exhibitor Data Sheet